Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
Katherine E. Talcott, MD
Christina Y. Weng, MD, MBA, FASRS
Roger A. Goldberg, MD, MBA
Identifying Central and Branch Retinal Vein Occlusion
Jessica Randolph, MD
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Ryan Quigley
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Deepak Sambhara, MD
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Esther Lee Kim, MD
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Chin Yee, MD, FASRS
GLP-1 Use and AMD Risk
Barton Lynn Blackorby, MD
Katharine Talcott, MD
Hong-Uyen Hua, MD
MH Risk Factors After RRD Repair
Maria H. Berrocal, MD
Avni P. Finn, MD, MBA
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Ashkan Abbey, MD
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Lejla Vajzovic, MD, FASRS
Practice Efficiency and Innovation
Jacob Lang
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Jennifer Caudle, DO, FACOFP
Michael Javaheri, MD, MSc, FASRS
Mapping the Landscape: Diagnostic Tools in Corneal Health
Paul Hammond, OD, FAAO
EMPOWER - Cornea Health Diagnostic Tools
Jacob Lang, OD, FAAO
Jason E. Compton, OD, FAAO
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.